Predoc is a technology company.
Predoc automates the exchange and utilization of patient health data, providing actionable and timely patient insights at a fraction of the cost.
Predoc has raised $30.0M across 1 funding round.
Predoc has raised $30.0M in total across 1 funding round.
Predoc has raised $30.0M in total across 1 funding round.
Predoc's investors include Base10 Partners, BlueRun Ventures, Khosla Ventures, Long Journey Ventures, MATR Ventures, Polychain Capital, SciFi VC, Akash Garg, Balaji Srinivasan, Justin David Blau, Scott Banister, Shayne Coplan.
Predoc is an AI-powered health information management platform that automates medical record retrieval, structuring, and analysis from U.S. healthcare providers, delivering complete records in minutes or days instead of weeks.[1][3][5] It serves oncology groups, research networks, and virtual care providers by consolidating fragmented data into actionable clinical insights, reducing retrieval times by up to 75% and clinical review time by 70%, while integrating into existing workflows without overhauls.[1][3][4] Founded in 2022, Predoc recently raised $30M to scale adoption, emphasizing AI that amplifies clinician judgment rather than replacing it.[1]
The platform extracts and indexes unstructured data from digital sources or PDFs, categorizes it with HIPAA-compliant AI, and surfaces relevant insights from hundreds of pages per patient, enabling faster patient qualification for care or trials.[1][3] Clients like oncology institutions have eliminated in-house records teams, sparing patients delays or physical burdens.[1]
Predoc was founded in 2022 as Memr Inc. by Nishant Hari, Dr. Kaushal Kulkarni, Dr. Priya Mehta, and Alex Daniels, targeting longstanding interoperability failures in fragmented U.S. healthcare systems.[1] The idea emerged from recognizing how manual record retrieval delays patient care, research, and virtual services; the team built an end-to-end AI platform to automate retrieval from all sources and generate human-validated insights.[1][3]
Early traction came from oncology and research clients reporting dramatic efficiency gains, such as one group fully outsourcing records management, paving the way for the $30M raise in September 2025 to expand across more provider networks.[1][4]
(Note: A separate entity, predoc.ai based in India and founded in 2020, focuses on audio-visual diagnostics like jaundice or COVID detection via smartphone cameras; this analysis centers on the U.S.-based Predoc per primary funding and platform details.[2])
Predoc rides the AI-healthcare interoperability wave, addressing U.S. data silos amid rising virtual care, oncology trials, and research demands post-2020s digitization push.[1][3] Timing aligns with regulatory tailwinds like FHIR standards and payer pressures for efficiency, plus AI maturity enabling accurate structuring of unstructured records (80%+ of health data).[1][4]
Market forces favor it: exploding trial patient volumes, clinician burnout from manual tasks, and $30M funding signaling VC bets on AI ops tools amid healthcare's trillion-dollar inefficiencies.[1][5] Predoc influences the ecosystem by accelerating insights for research networks, potentially standardizing data flows and enabling faster therapies.
Predoc is poised to dominate health info management as AI scales in healthcare, with next steps including broader oncology/research adoption and possible international expansion via its funding.[1] Trends like multimodal AI and real-time data mandates will amplify its edge, evolving it from ops tool to ecosystem enabler for precision care. As interoperability failures persist, Predoc's automation could redefine how fragmented systems fuel patient outcomes, tying back to its core mission of turning records into rapid, actionable insights.[1][3]
Predoc has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $30.0M Series A | Base10 Partners, BlueRun Ventures, Khosla Ventures, Long Journey Ventures, MATR Ventures, Polychain Capital, SciFi VC, Akash Garg, Balaji Srinivasan, Justin David Blau, Scott Banister, Shayne Coplan |